Please note: Our next Awareness Night is Wed. Nov. 22, not Nov. 29 as has appeared in some places.

PSA Screening

New IsoPSA assay detects prostate cancer more precisely than current tests

July 2, 2017

A team of researchers from Cleveland Clinic, Louis Stokes Cleveland VA Medical Center, Kaiser Permanente Northwest, and other clinical sites have demonstrated that a new blood test known as IsoPSA detects prostate cancer more precisely than current tests in two crucial measures – distinguishing cancer from benign conditions, and identifying patients with high-risk disease. Read […]

Read the article or watch the video →

Video: “The Prostate Gland and Testosterone: relationship, importance to overall health, and the impact of prostate cancer and treatment on one’s health”

May 5, 2017

March 2017 Awareness Night The Prostate Gland and Testosterone: relationship, importance to overall health, and the impact of prostate cancer and treatment on one’s health Dr. Joseph R. LaBossiere, BMSc, MD, MSc, FRCSC Reconstructive Urology Fellow, Sunnybrook Health Sciences Centre             CLICK ON THE ARROW TO START THE VIDEO The […]

Read the article or watch the video →

Video: “The Future of PSA Based Prostate Cancer (PCa) Screening – Screening Smarter and Individualized Risk Assessment”

March 3, 2017

January 2017 Awareness Night The Future of PSA Based Prostate Cancer (PCa) Screening – Screening Smarter and Individualized Risk Assessment Dr. Raj Satkunasivam, MD, MS, FRCSC Urologic Oncologist,  Odette Cancer Centre, Sunnybrook Health Sciences Centre Assistant Professor, Division of Urology, Department of Surgery, University of Toronto     CLICK ON THE ARROW TO START THE […]

Read the article or watch the video →

Prostate Multiparametric MRI Feasible for PCa Screening

February 19, 2017

Robert K. Nam, MD, from the Sunnybrook Health Sciences Center in Toronto, and colleagues examined the feasibility of prostate MRI as the primary screening test for prostate cancer in a cohort of unselected men from the general population. All participants underwent prostate multiparametric MRI and random or targeted biopsies as well as prostate-specific antigen testing. […]

Read the article or watch the video →

Rise in Prostate Cancer Deaths Stems from Testing Recommendations

January 12, 2017

From ZEROHour Newsletter: January 2017 The newly released “2017 Cancer Facts and Figures” report shows the negative impact of the USPSTF recommendation against the PSA test. Read the Newsletter.

Read the article or watch the video →

New prostate cancer test strives to slash biopsies

January 2, 2017

Because PSA is secreted both by normal cells and cancer cells, its levels could be high for other reasons and not necessarily cancer: age, an inflammation of the prostate gland, or even a bicycle ride. But most often when doctors receive a high reading, they send their patients to do a biopsy, just to be […]

Read the article or watch the video →

20th Anniversary Video

December 2, 2016

November 2014 Awareness Night – 20th Anniversary Celebration Watch this video of our 20th anniversary celebration: A bit of history from our founding as Man to Man to our joining the Prostate Cancer Canada Network Congratulatory messages from the medical community Our position on PSA testing as presented by PCC’s President and CEO Rocco Rossi […]

Read the article or watch the video →

High PSA levels in middle-age men could indicate higher risk for prostate cancer

October 23, 2016

A new study published in the Journal of Clinical Oncology has found that men who have higher-than-normal prostate-specific antigen (PSA) levels in middle age are more likely to have fatal prostate cancer later in life. Read the article here.

Read the article or watch the video →

PSA test best at predicting lethal prostate cancer, study says

October 23, 2016

Prostate specific antigen, or PSA, tests correctly predicted whether a man would have lethal prostate cancer later in life more than three-quarters of the time, researchers at Harvard University report in a new study. Read the article here.

Read the article or watch the video →

Landmark PSA Screening Trial Results Challenged

July 24, 2016

Recommendations against routine PSA screening from the US Preventive Services Task Force (USPSTF) are based largely on a landmark trial showing that such screening does not decrease the risk of death from prostate cancer (PCa), but this conclusion may be invalid. Read the article.

Read the article or watch the video →